GSK3B and neoplasm: The overexpression of miR-29a, miR-221, miR-222, and miR-130b stimulates the proliferation of tumor cells by activating PI3K/AKT and targeting several tumor suppressors, such as glycogen synthase kinase 3β (GSK3β) and PTEN (31).